Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. - Wikidata - awgldk - TriplyDB

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

http://www.wikidata.org/entity/Q36774059

about

Plasmapheresis in immunologic renal disease Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both?Therapeutic plasma exchange and renal related vasculitis: therapeutic apheresis academy 2010.Neurologic indications for therapeutic plasma exchange: an update.The role of therapeutic plasma exchange in poisonings and intoxications.Neurologic indications for therapeutic plasma exchange: 2011 update.Neurologic indications for therapeutic plasma exchange: 2013 update.Thrombotic thrombocytopenic purpura and sickle cell crisis.Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects.Therapeutic apheresis in autoimmune diseases.Comparative analysis of therapeutic options used for myasthenia gravis.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Optimal management of familial hypercholesterolemia: treatment and management strategies Therapeutic plasma apheresis as a treatment for 35 severely ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report Development of electronic medical record charting for hospital-based transfusion and apheresis medicine services: Early adoption perspectives.Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis.Role of plasma exchange in the thyroid storm.Therapeutic apheresis in pediatrics: technique adjustments, indications and nonindications, a plasma exchange focus.Prevention and treatment of cardiovascular disease in women: the obstetric-gynecologist's point of view.Exchange transfusion for severe malaria: evidence base and literature review.Thyroid storm: an updated review.How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedures.Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature.The ABC of apheresis.Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin.Can plasma exchange therapy induce regulatory T lymphocytes in multiple sclerosis patients?Severe Uncompensated Metabolic Alkalosis due to Plasma Exchange in a Patient with Pulmonary-Renal Syndrome: A Clinician's Challenge.Therapeutic plasma exchange in acute disseminated encephalomyelitis in children.Therapeutic Apheresis - Many Ways to Go.Recent advances in diagnosis and treatment of atypical haemolytic uraemic syndrome.Acute cholestatic hepatitis a virus infection presenting with hemolytic anemia and renal failure: a case report.Use of plasmapheresis in managing the diagnostic dilemma of symptomatic hypertriglyceridemia.Surviving the storm: two cases of thyroid storm successfully treated with plasmapheresis.Plasma exchange in severe leptospirosis with multi-organ failure: a case report.The Fifth Annual Therapeutic Apheresis Academy: continuity and changes.Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.

P2860

Q27027106-5C421EEF-5A43-4DC0-B3E7-D9A3A875CAAB Q30252073-844A9D63-A8B9-472A-BC62-5039628D80F6 Q30454083-9D4AC0BD-CA99-4C56-94D0-7CE27890C557 Q30454297-2B6BBF39-A622-408C-981B-4D7D81F3798E Q30455129-1CC5D61E-A24A-40FA-BE1E-6279F0BE0AEA Q30455391-6FCC4794-411F-43BA-890A-2A96FDAB18EE Q30458271-7C3E30F7-ECE6-466E-A456-EAAFAF330014 Q33381438-81CCC26F-87A5-4643-9729-511D946E0F78 Q33383006-612013F9-9D8B-4837-96F3-9FACB3CABBD9 Q33393870-D2BDD197-945A-4BAB-A6FD-1D03FE952F12 Q33436347-54AA54F8-4893-4934-A0BF-AC37A8052616 Q34024635-B7978851-979B-412A-A5B9-360D8CA90316 Q34122035-89B1317C-33D0-4BD3-BC0F-2AE8F7E53490 Q34417480-4BE9D4AF-698D-47ED-99AE-D3512C0B228A Q35121636-D163AA64-C36C-470D-A5C4-63000926C10A Q37065608-8D3FDEEE-0A86-4C02-B387-D592E7911274 Q37784144-9D464DA7-3A1B-441B-B280-CB18AFC62A60 Q37820338-DB5CA865-8284-4546-A6A2-32D440C99888 Q37924703-3298C083-D575-4ACE-B978-99BDFE85D7B6 Q37959584-C439DEEB-3527-49BF-BDAB-A5F52070A8AF Q37998979-70D096AB-2DA2-449D-ABD3-71210FE47CA5 Q38095646-C8B4641E-8A98-4A82-8B7F-B76FA787B2E2 Q38117035-9DF35196-24B1-4763-8484-865D23BF35DC Q38126986-FACB2623-C5C4-4C78-A4D2-ACA70154D941 Q38164817-12C8563D-2746-45C3-ACCE-AB32719607F3 Q38216786-400C313B-C110-4BA7-8192-F1CA03C082AE Q38264694-12AA787D-EBA0-437E-96E4-ACEC3A124228 Q38269605-ED50526D-022E-4FFF-92AF-08752273FE5A Q38955520-37EE4529-00D0-4153-ACB5-308EB857086A Q39645552-E398638C-CFBB-4E59-AB1C-795E2BA69CE5 Q40147650-F1D40607-0964-4F54-995F-EBDE322F2349 Q40581951-3F817271-35D0-4F5B-9321-5CA0413325D7 Q41826655-C84DCEF2-16D1-46FC-B662-9D991319F805 Q42047135-AD521E16-4923-40DF-B002-AF0C3D36C6DE Q42156722-B8F41025-2CE5-4C17-AA9A-08C8B3680E2E Q42427122-292DF9E5-DE3D-440D-9FFC-8722FC7ECA15 Q42715748-1DE4F99B-691C-4A70-85CF-C2FDC44282B8 Q43106918-5EFA08CE-7F59-4D23-9833-3B7808679463 Q43525232-3A7AD651-2085-4CE0-9B24-670DF7F369AB Q44793703-40DA5B7D-34DE-41B2-BB8A-750147704420

P2860

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

http://www.wikidata.org/entity/Q36774059

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Guidelines on the use of thera ...... merican Society for Apheresis.

@ast

Guidelines on the use of thera ...... merican Society for Apheresis.

@en

type

label

Guidelines on the use of thera ...... merican Society for Apheresis.

@ast

Guidelines on the use of thera ...... merican Society for Apheresis.

@en

prefLabel

Guidelines on the use of thera ...... merican Society for Apheresis.

@ast

Guidelines on the use of thera ...... merican Society for Apheresis.

@en

P1433

Q36774059-F7A1C044-8B32-497D-BF35-BA8CCF29075D

P1476

Q36774059-86E69F8D-8DBE-4BDF-B32B-F7600ADDAF37

P2093

Q36774059-109AD32F-F050-4276-BDC2-6501CD6B8AD1

Q36774059-5FE7BFC5-F3A0-4706-A8C5-681FB4D6DBAD

Q36774059-777ECAC2-614A-41C6-9C48-FEF95D5C449B

Q36774059-814A7B5D-042E-4729-9A2B-8B6D90E3041D

Q36774059-824433DC-413D-491D-8446-0ED59213B420

Q36774059-9069A98F-EC0E-4064-8CB1-799D563424C5

Q36774059-9C439729-4278-4786-80D3-D56047E85495

Q36774059-A24AE5DB-0721-4F89-A7BA-4A3785CE92F4

Q36774059-B411EE0E-A7DE-4025-8012-CA16B1672DBF

Q36774059-CC193C2D-1F97-48DD-B4C1-03173C22DF93

P2860

Q36774059-017B29C7-F25B-4752-9AA0-6C4CDF147097

Q36774059-1B33A553-8531-4A7A-A136-4B124F04F037

Q36774059-1CCE5A5A-8A23-4393-BFD3-3ACB451182B8

Q36774059-1DEC1DA0-5CC1-4434-A4F6-528C383DCC1E

Q36774059-2858776D-1BF9-4E63-9BB2-900683DBE991

Q36774059-491479C2-6441-4133-8851-556AEAF6BA6D

Q36774059-50B1AFA0-63E9-41E1-AFDE-616E537D689D

Q36774059-60CF4C8B-FE8A-497F-95DF-B5B9D89D6E1B

Q36774059-712BD132-8B5C-48FB-B5DD-E664BF75683C

Q36774059-7D39113B-E3CC-4386-9031-E318B78CD236

P304

Q36774059-8A0945E8-734E-481A-B1C2-7E5206696CE9

P31

Q36774059-38D1EA5A-BC6B-4758-9AF6-595E5167C485

P356

Q36774059-52737F18-91B0-4117-AC4F-927F90A55F1F

P433

Q36774059-151B4F06-CC5F-470F-85E8-E551A2278B7C

P478

Q36774059-0445A161-D7FA-487B-9331-902953F7F377

P50

Q36774059-96217C8E-B063-49E8-8FCF-904BCFF64392

Q36774059-B71A6204-45A1-4472-9AD5-FECE9E703C00

Q36774059-F5D05F85-C9F5-4227-9EA7-FBA2F7F14F78

P577

Q36774059-F88959D0-7677-4A41-A2CE-11B5C21C4EEC

P5875

Q36774059-9B367155-10D7-432A-A057-C8AE1C570467

P698

Q36774059-6BB59656-AF72-4A24-9F74-1F9B7F251053

P356

P1433

Journal of Clinical Apheresis

P1476

Guidelines on the use of thera ...... merican Society for Apheresis.

@en

P2093

American Society for Apheresis

http://www.w3.org/2001/XMLSchema#string

Apheresis Applications Committee of the American Society for Apheresis

http://www.w3.org/2001/XMLSchema#string

Ashka Wirk

http://www.w3.org/2001/XMLSchema#string

Beth H Shaz

http://www.w3.org/2001/XMLSchema#string

Haewon C Kim

http://www.w3.org/2001/XMLSchema#string

Michael L Linenberger

http://www.w3.org/2001/XMLSchema#string

Nicholas Bandarenko

http://www.w3.org/2001/XMLSchema#string

Ravindra Sarode

http://www.w3.org/2001/XMLSchema#string

Robert Weinstein

http://www.w3.org/2001/XMLSchema#string

Zbigniew M Szczepiorkowski

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome.

Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients.

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS).

Focal seizures due to chronic localized encephalitis.

Pathophysiology and therapy of pemphigus in the 21st century.

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy.

Stiff-man syndrome updated.

Prevention and treatment of secondary hyperparathyroidism: still a challenge for the nephrologist?

What's new in the management of cutaneous T-cell lymphoma?

P304

106-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCA.20129

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey L. Winters

Marisa B. Marques

Joseph Schwartz

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51377601

http://www.w3.org/2001/XMLSchema#string

P698

17394188

http://www.w3.org/2001/XMLSchema#string